Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT03580616 · TERMINATED
Trial details
- NCT number
- NCT03580616
- Sponsor
- Elijah W. Stommel
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-24
- Primary completion
- 2022-08-03
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.